Hira Tariq
Services Institute of Medical Sciences, Pakistan · Senior Registrar Department of Dermatology Services Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Hira Tariq as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:57 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT06591273 · Efficacy and Safety of Infliximab Biosimilar in Treatment of Moderate to Severe Psoriasis; A Single-arm Clinical TrialServices Institute of Medical Sciences, Pakistan · unknown · Moderate to Severe Chronic Plaque Psoriasis · principal investigator
- Ph4NCT06032858 · Efficacy and Safety of Apremilast in PsoriasisGhurki Trust and Teaching Hospital · completed · Psoriasis · study chair
- Early Ph1NCT05663268 · Efficacy and Safety of Infliximab Biosimilar in the Treatment of Resistant Hidradenitis SuppurativaServices Institute of Medical Sciences, Pakistan · completed · Hidradenitis Suppurativa · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:57 UTC. The ranking covers the 200 most relevant of 1 PubMed records, and a shared surname and initials can bring in a namesake. All 1 on PubMed
- Open method versus capitonnage in management of hepatic hydatidosis in children.Pediatr Surg Int · 20011 citationsRCR 0.0